These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3522440)

  • 21. Technical standards for medical devices. Assisted circulation devices.
    Clemente F; Ferrari GF; De Lazzari C; Tosti G
    Technol Health Care; 1997 Dec; 5(6):449-59. PubMed ID: 9696163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart-rate alarms on ZMI ZOLL PD 1200 pacemaker/defibrillators.
    Health Devices; 1990 Dec; 19(12):455-6. PubMed ID: 2262328
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac device therapy 1: theory, technology and terminology.
    Modi S; Rao A; Hughes S; Ramsdale D
    Br J Hosp Med (Lond); 2008 Nov; 69(11):620-4. PubMed ID: 19069261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative testing of artificial hearts and heart valves in a mock circulation.
    Klain M
    Adv Biomed Eng Med Phys; 1970; 3():131-60. PubMed ID: 5527786
    [No Abstract]   [Full Text] [Related]  

  • 25. The evolution of cardiac assist device technology.
    Jeevanandam V
    J Heart Lung Transplant; 2010 Jan; 29(1):11-2. PubMed ID: 19783162
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA reform: new law to impact EP and pacing services at home and abroad.
    Morgan A
    Pacing Clin Electrophysiol; 1998 Mar; 21(3):610-2. PubMed ID: 9558694
    [No Abstract]   [Full Text] [Related]  

  • 27. Charge! FDA recommendations for maintaining defibrillator readiness.
    White RD; Chesemore KF
    JEMS; 1992 Apr; 17(4):70-2, 82. PubMed ID: 10117528
    [No Abstract]   [Full Text] [Related]  

  • 28. Continuous-flow total artificial heart port-to-port connection technique using dedicated de-airing sleeve.
    Karimov JH; Gao S; Fukamachi K; Grady P
    Perfusion; 2020 Nov; 35(8):861-864. PubMed ID: 32375546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese guidance for ventricular assist devices/total artificial hearts.
    Yamane T; Kyo S; Matsuda H; Abe Y; Imachi K; Masuzawa T; Nakatani T; Sase K; Tabayashi K; Takatani S; Tatsumi E; Umezu M; Tsuchiya T
    Artif Organs; 2010 Sep; 34(9):699-702. PubMed ID: 20883387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Past, present, and future regulatory aspects of ventricular assist devices.
    Patel-Raman SM; Chen EA
    J Cardiovasc Transl Res; 2010 Dec; 3(6):600-3. PubMed ID: 21046301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-specific outcomes for HeartMate II.
    Dhruva SS; Redberg RF
    J Am Coll Cardiol; 2011 Sep; 58(12):1285; author reply 1285-6. PubMed ID: 21903068
    [No Abstract]   [Full Text] [Related]  

  • 33. AAMI biomedical standards available.
    Hammer GS
    Med Instrum; 1975; 9(6):281-2. PubMed ID: 1081188
    [No Abstract]   [Full Text] [Related]  

  • 34. Effective date of requirement for premarket approval for cardiovascular permanent pacemaker electrode. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Jul; 77(130):39924-7. PubMed ID: 22792583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remote monitoring of patients with cardiac implantable electronic devices: maximizing gains by addressing workflow.
    Varma N
    Europace; 2013 Jul; 15(7):921-3. PubMed ID: 23594932
    [No Abstract]   [Full Text] [Related]  

  • 36. Author reply: To PMID 23362021.
    Ricci RP;
    Europace; 2014 Jul; 16(7):1099-100. PubMed ID: 24567236
    [No Abstract]   [Full Text] [Related]  

  • 37. Designing trials for testing prosthetic cardiac valves: a Food and Drug Administration perspective.
    Sapirstein W
    Am Heart J; 2001 May; 141(5):861-3. PubMed ID: 11320379
    [No Abstract]   [Full Text] [Related]  

  • 38. Defibrillator/monitor/pacemakers.
    Health Devices; 1993; 22(5-6):211-94. PubMed ID: 8253590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Device therapy for the management of advanced heart failure.
    Krishnamani R; DeNofrio D
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):573-80. PubMed ID: 15225116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Task force V: physical interventions and adjunctive therapy. Emergency cardiac care.
    Parmley WW; Hatcher CR; Ewy GA; Frommer PL; Furman S; Leinbach RC; Redding J; Symbas PN; Weisfeldt ML
    Am J Cardiol; 1982 Aug; 50(2):409-19. PubMed ID: 6285686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.